A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis

Published:2009-01 Issue:1 Volume:179 Page:75-79
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Veziris Nicolas,Ibrahim Murad,Lounis Nacer,Chauffour Aurelie,Truffot-Pernot Chantal,Andries Koen,Jarlier Vincent

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference18 articles.

1. Global Burden of Tuberculosis

2. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

3. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

4. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid

5. Efficient Intermittent Rifapentine-Moxifloxacin-Containing Short-Course Regimen for Treatment of Tuberculosis in Mice

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of pyrazinamide resistance in Mycobacterium tuberculosis using structure-based machine-learning approaches;JAC-Antimicrobial Resistance;2024-03-05

2. Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2023-12-22

3. Recent developments in the identification and biosynthesis of antitumor drugs derived from microorganisms;Engineering Microbiology;2022-12

4. Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data;The Journal of Infectious Diseases;2021-02-19

5. Fully weekly antituberculosis regimen: a proof-of-concept study;European Respiratory Journal;2020-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3